Teneligliptin protects against ischemia/reperfusion-induced endothelial permeability in vivo and in vitro
Author:
Affiliation:
1. Department of Neurology
2. The First Affiliated Hospital of Xi'an Medical University
3. Xi'an
4. China
5. Shaanxi Key Laboratory of Brain Disorders
6. Department of General Surgery
7. The Second Affiliated Hospital of Xi'an Jiaotong University
Abstract
Ischemic stroke is a leading cause of disability and mortality worldwide, especially among the elderly population.
Funder
ShanXi Science and Technology Department
Publisher
Royal Society of Chemistry (RSC)
Subject
General Chemical Engineering,General Chemistry
Link
http://pubs.rsc.org/en/content/articlepdf/2020/RA/C9RA08810E
Reference35 articles.
1. I. S.Party , National clinical guideline for stroke , London , Royal College of Physicians , 2012 Sep
2. Endovascular Treatment for Acute Ischemic Stroke
3. Blood-brain barrier, reperfusion injury, and hemorrhagic transformation in acute ischemic stroke
4. A multifactorial analysis of risk factors for recurrence of ischemic stroke.
5. Stroke
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Teneligliptin: A potential therapeutic approach for diabetic cardiomyopathy;World Journal of Diabetes;2024-08-15
2. Ferulic Acid Methyl Ester Attenuates Cerebral Ischemia-Reperfusion Injury in Rats by Modulating PI3K/HIF-1α/VEGF Signaling Pathway;Journal of Inflammation Research;2024-08
3. Netrin‐1 protects blood–brain barrier (BBB) integrity after cerebral ischemia‐reperfusion by activating the Kruppel‐like factor 2 (KLF2)/occludin pathway;Journal of Biochemical and Molecular Toxicology;2024-01
4. Finding the most cost-effective option from commonly used Dipeptidyl peptidase-4 inhibitors in India: a systematic study;Expert Review of Endocrinology & Metabolism;2023-05-26
5. Effect of Switching from Linagliptin to Teneligliptin Dipeptidyl Peptidase-4 Inhibitors in Older Patients with Type 2 Diabetes Mellitus;Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy;2020-11
Effect of Switching from Linagliptin to Teneligliptin Dipeptidyl Peptidase-4 Inhibitors in Older Patients with Type 2 Diabetes Mellitus
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3